Management of graft failure and erythroblastopenia in patients undergoing allogeneic hematopoietic stem cell transplantation : Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Copyright © 2016. Published by Elsevier Masson SAS..
Success of allogeneic hematopoietic stem cells transplantation requires both the underlying disease eradication and satisfying reconstitution of hematopoiesis from donor cells. However, reconstitution delays, secondary development or persistence of cytopenia are regularly observed and are potential causes of failure after allogeneic transplantation. These graft dysfunctions should be distinguished from non-engraftment/engraftment failure. Although these situations are relatively common, there is no consensus in the literature for their management. During the workshop of the SFGM-TC, the working group proposed recommendations from an analysis of the literature.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:103 |
|---|---|
| Enthalten in: |
Bulletin du cancer - 103(2016), 11S vom: 01. Nov., Seite S248-S254 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Dysfonctionnement du greffon et érythroblastopénie après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) |
|---|
| Beteiligte Personen: |
Cornillon, Jérôme [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 03.02.2017 Date Revised 03.02.2017 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bulcan.2016.09.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM265895669 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM265895669 | ||
| 003 | DE-627 | ||
| 005 | 20231224213310.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.bulcan.2016.09.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0886.xml |
| 035 | |a (DE-627)NLM265895669 | ||
| 035 | |a (NLM)27810141 | ||
| 035 | |a (PII)S0007-4551(16)30215-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Cornillon, Jérôme |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Management of graft failure and erythroblastopenia in patients undergoing allogeneic hematopoietic stem cell transplantation |b Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) |
| 246 | 3 | 3 | |a Dysfonctionnement du greffon et érythroblastopénie après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.02.2017 | ||
| 500 | |a Date Revised 03.02.2017 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2016. Published by Elsevier Masson SAS. | ||
| 520 | |a Success of allogeneic hematopoietic stem cells transplantation requires both the underlying disease eradication and satisfying reconstitution of hematopoiesis from donor cells. However, reconstitution delays, secondary development or persistence of cytopenia are regularly observed and are potential causes of failure after allogeneic transplantation. These graft dysfunctions should be distinguished from non-engraftment/engraftment failure. Although these situations are relatively common, there is no consensus in the literature for their management. During the workshop of the SFGM-TC, the working group proposed recommendations from an analysis of the literature | ||
| 650 | 4 | |a Consensus Development Conference | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Allogreffe de cellules souches hématopoïétiques | |
| 650 | 4 | |a Bone marrow transplantation | |
| 650 | 4 | |a Dysfonction du greffon | |
| 650 | 4 | |a Erythroblastopenia | |
| 650 | 4 | |a Graft dysfunction | |
| 650 | 4 | |a Érythroblastopénie | |
| 700 | 1 | |a Sicre de Fontbrune, Flore |e verfasserin |4 aut | |
| 700 | 1 | |a Chantepie, Sylvain |e verfasserin |4 aut | |
| 700 | 1 | |a Coiteux, Valérie |e verfasserin |4 aut | |
| 700 | 1 | |a Gauthier, Jordan |e verfasserin |4 aut | |
| 700 | 1 | |a Masouridi-Levrat, Stavroula |e verfasserin |4 aut | |
| 700 | 1 | |a Pochon, Cécile |e verfasserin |4 aut | |
| 700 | 1 | |a Terriou, Louis |e verfasserin |4 aut | |
| 700 | 1 | |a Yakoub-Agha, Ibrahim |e verfasserin |4 aut | |
| 700 | 1 | |a Dalle, Jean-Hugues |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bulletin du cancer |d 1966 |g 103(2016), 11S vom: 01. Nov., Seite S248-S254 |w (DE-627)NLM000155853 |x 1769-6917 |7 nnns |
| 773 | 1 | 8 | |g volume:103 |g year:2016 |g number:11S |g day:01 |g month:11 |g pages:S248-S254 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bulcan.2016.09.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 103 |j 2016 |e 11S |b 01 |c 11 |h S248-S254 | ||